Adjuvant chemoradiotherapy versus radical surgery after transanal endoscopic microsurgery for intermediate pathological risk early rectal cancer: A single-center experience with long-term surveillance.

Surgery 2022 Vol.171(4) p. 882-889

Li Y, Qiu X, Shi W, Lin G

관련 도메인

Abstract

[BACKGROUND] The choice of subsequent treatment for intermediate-risk rectal tumors after transanal endoscopic microsurgery between adjuvant chemoradiotherapy and total mesorectal excision is controversial. The present study aimed to compare survival and functional outcome between these 2 strategies.

[METHODS] This retrospective study included intermediate-risk patients with early rectal cancer after transanal endoscopic microsurgery in our center between 2010 and 2017. Patients were divided into adjuvant treatment and total mesorectal excision groups. Intermediate risk was defined as pT1 with lymphovascular invasion, poor differentiation, or large diameter (3-5 cm) or pT2 with small diameter (<3 cm). The study was based on follow-up data on survival and results from distributed validated scales for functional outcome.

[RESULTS] Postoperative overall survival and disease-free survival were comparable between the groups (P = .619 and P = .712, respectively). Pathological T stage was an independent risk factor for disease-free survival (hazard ratio 3.09, 95% confidence interval 1.66-4.18, P = .044). Anorectal symptoms, such as buttock pain, were significantly prevalent in the total mesorectal excision group (P = .030). In addition, the total mesorectal excision group presented with poorer bowel function, including stool urgency (P < .001), bowel frequency (P = .016), severity of low anterior resection syndrome (P = .039) and total low anterior resection syndrome score (P = .040). Except for a lower score of vaginal lubrication in the total mesorectal excision versus the adjuvant treatment group, sexual function was similar between the groups.

[CONCLUSION] Similar to total mesorectal excision, adjuvant chemoradiotherapy is an alternative option for intermediate-risk early rectal cancer after transanal endoscopic microsurgery and is associated with similar survival outcomes and better bowel function.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 4
기법 endoscopic 내시경 dict 4
해부 buttock scispacy 1
해부 bowel scispacy 1
합병증 vaginal scispacy 1
약물 chemoradiotherapy C0436307
Chemoradiotherapy
scispacy 1
약물 [BACKGROUND] scispacy 1
질환 cancer C0006826
Malignant Neoplasms
scispacy 1
질환 tumors C0027651
Neoplasms
scispacy 1
질환 pT2 C0332392
pT2 Stage Finding
scispacy 1
질환 buttock pain C0231710
Pain in buttock
scispacy 1
질환 poorer bowel function scispacy 1
질환 low anterior resection syndrome C4524073
Low Anterior Resection Syndrome
scispacy 1
질환 rectal cancer scispacy 1
질환 rectal tumors scispacy 1
질환 pT1 scispacy 1
기타 patients scispacy 1
기타 lymphovascular scispacy 1
기타 stool scispacy 1
기타 anterior scispacy 1

MeSH Terms

Chemoradiotherapy, Adjuvant; Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Complications; Rectal Neoplasms; Retrospective Studies; Syndrome; Transanal Endoscopic Microsurgery; Treatment Outcome

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문